Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

40results about How to "Tight regulation" patented technology

Vertically packaged switched-mode power converter

A vertically packaged cellular power converter solves the problems associated with conventional designs and paves the way for a cellular circuit architecture with ultra-low interconnect resistance and inductance. The vertical packaging results in a power flow in the vertical direction (from the bottom to the top) with very short internal interconnects, thereby minimizing the associated conduction losses and permitting high conversion efficiency at high currents. The cellular architecture is ideally suited for generating multiple supply voltages.
Owner:MYPAQ HLDG LTD

Vertically packaged switched-mode power converter

A vertically packaged cellular power converter solves the problems associated with conventional designs and paves the way for a cellular circuit architecture with ultra-low interconnect resistance and inductance. The vertical packaging results in a power flow in the vertical direction (from the bottom to the top) with very short internal interconnects, thereby minimizing the associated conduction losses and permitting high conversion efficiency at high currents. The cellular architecture is ideally suited for generating multiple supply voltages.
Owner:MYPAQ HLDG LTD

Methods, systems and apparatus for separation and isolation of one or more sample components of a sample biological material

Devices, systems and methods for use in separating sample materials into different sample components and then isolating one or more of the sample components for further processing or analysis are disclosed. Devices employ configurations that optionally allow a sample material to be electrophoretically separated into sample components in a separation matrix within a separation conduit. The sample components may then be detected in a detection zone in the separation conduit, and then selected components shunted to a component collection conduit within the device downstream of the detection zone for further processing or analysis based on information received at the detection zone. Methods of using these devices, and systems that incorporate these devices are also envisioned.
Owner:CAPLIPER LIFE SCI INC

Secretion signal vectors

InactiveUS7071172B2Minimize potential deleterious side effectAttenuate seizure activityBiocideAnimal repellantsHeterologousAdeno associate virus
The present invention provides delivery vectors for transferring a nucleic acid sequence to a cell in vitro, ex vivo or in vivo. The delivery vector comprises a segment encoding a secretory signal peptide. In embodiments of the invention, the delivery vector is an adeno-associated virus (AAV) vector. In other embodiments, the secretory signal peptide is a fibronectin secretory signal peptide (including variations and modifications, thereof). The delivery vectors of the invention may further comprise a heterologous nucleic acid sequence encoding a polypeptide of interest for transfer to a target cell, where the polypeptide of interest is operably associated with the secretory signal. Also disclosed are methods of transferring a nucleic acid of interest to a cell using the delivery vectors of the invention.
Owner:THE UNIV OF NORTH CAROLINA AT CHAPEL HILL

Programmable Step-Down Switching Voltage Regulators with Adaptive Power MOSFETs

A step-down switching voltage regulator includes M high-side switches connected between an input voltage and a node; N synchronous rectifiers connected between the node Vx and a ground voltage and an inductor connected between an input voltage and a node Vx and an inductor connected between the node Vx and an output node. An interface circuit decodes a control signal to identify: 1) a subset (m) of the high-side switches, 2) a subset (n) of the synchronous rectifiers. A control circuit drives the high-side switches and synchronous rectifiers in a repeating sequence that includes an inductor charging phase where the high-side switches in the subset m are activated to connect the node Vx to the input voltage; and an inductor discharging phase where the synchronous rectifiers in the subset n are activated to connect the node Vx to the ground voltage.
Owner:ADVANCED ANALOGIC TECHNOLOGIES INCORPORATED

Carbamate compositions and methods fo rmodulating the activity of the CHK1 enzyme

Described herein are carbamate compounds. Such compounds are capable of modulating the activity of a checkpoint kinase, and described herein are methods for utilizing such modulation to treat cell proliferative disorders. Also described are pharmaceutical compositions containing such compounds. Also described are the therapeutic or prophylactic use of such compounds and compositions, and methods of treating cancer as well as other diseases associated with unwanted cellular proliferation, by administering effective amounts of such compounds in combination with anti-neoplastic agents.
Owner:AGOURON PHARMA INC

Vasodilator-enhanced cardiopulmonary resuscitation

InactiveUS20120203147A1Increase blood flowImprove artificial circulationBiocideHeavy metal active ingredientsImpedance threshold deviceVascular dilatation
A method for increasing blood flow to vital organs during cardiopulmonary resuscitation of a person experiencing a cardiac arrest may include performing standard or active compression decompression cardiopulmonary resuscitation on a person to create artificial circulation by repetitively compressing the person's chest such that the person's chest is subject to a compression phase and a relaxation or decompression phase. The method may also include administering one or more vasodilator drugs to the person to improve the artificial circulation created by the cardiopulmonary resuscitation. The method may also include binding at least a portion of the person's abdomen, either manually or with an abdominal compression device. Performing cardiopulmonary resuscitation on a person may include ventilating the person with either an impedance threshold device or a intrathoracic pressure regulator.
Owner:ZOLL MEDICAL CORPORATION

Triple voltage dc-to-dc converter and method

A circuit and method of providing three dc voltage buses and transforming power between a low voltage dc converter and a high voltage dc converter, by coupling a primary dc power circuit and a secondary dc power circuit through an isolation transformer; providing the gating signals to power semiconductor switches in the primary and secondary circuits to control power flow between the primary and secondary circuits and by controlling a phase shift between the primary voltage and the secondary voltage. The primary dc power circuit and the secondary dc power circuit each further comprising at least two tank capacitances arranged in series as a tank leg, at least two resonant switching devices arranged in series with each other and arranged in parallel with the tank leg, and at least one voltage source arranged in parallel with the tank leg and the resonant switching devices, said resonant switching devices including power semiconductor switches that are operated by gating signals. Additional embodiments having a center-tapped battery on the low voltage side and a plurality of modules on both the low voltage side and the high voltage side are also disclosed for the purpose of reducing ripple current and for reducing the size of the components.
Owner:UT BATTELLE LLC

Voltage adapter for a battery-powered camera system

A voltage adapter for a battery-powered camera, including a boost regulating circuit, which is positionable between a camera and a camera battery. The power adapter being in communication with the battery and an appliance (e.g., a camera, a light, etc.) such that a constant boosted voltage (e.g., greater than the output voltage of the battery) is supplied to the appliance as the battery discharges. In a preferred embodiment the power supply further includes a buck regulator to maintain the proper output voltage when the battery voltage is greater than the output voltage.
Owner:HOLMES FRED +1

Programmable Step-Up Switching Voltage Regulators with Adaptive Power MOSFETs

A step-up switching voltage regulator includes an inductor connected between an input voltage and a node Vx, M low-side switches connected between the node Vx and a ground voltage and N synchronous rectifiers connected between the node Vx and an output node. An interface circuit that decodes a control signal to identify: 1) a subset (m) of the low-side switches, 2) a subset (n) of the synchronous rectifiers, and 3) a reference voltage Vref. A control circuit drives the synchronous rectifiers and low-side switches in a repeating sequence that includes an inductor charging phase where the low-side switches in the subset m are activated to connect the node Vx to the ground voltage; and an inductor discharging phase where the synchronous rectifiers in the subset n are activated to connect the node Vx to the output node.
Owner:ADVANCED ANALOGIC TECHNOLOGIES INCORPORATED

Triple voltage DC-to-DC converter and method

A circuit and method of providing three dc voltage buses and transforming power between a low voltage dc converter and a high voltage dc converter, by coupling a primary dc power circuit and a secondary dc power circuit through an isolation transformer; providing the gating signals to power semiconductor switches in the primary and secondary circuits to control power flow between the primary and secondary circuits and by controlling a phase shift between the primary voltage and the secondary voltage. The primary dc power circuit and the secondary dc power circuit each further comprising at least two tank capacitances arranged in series as a tank leg, at least two resonant switching devices arranged in series with each other and arranged in parallel with the tank leg, and at least one voltage source arranged in parallel with the tank leg and the resonant switching devices, said resonant switching devices including power semiconductor switches that are operated by gating signals. Additional embodiments having a center-tapped battery on the low voltage side and a plurality of modules on both the low voltage side and the high voltage side are also disclosed for the purpose of reducing ripple current and for reducing the size of the components.
Owner:UT BATTELLE LLC

Omni voltage direct current power supply

A battery operated LED lighting apparatus including: a battery outputting a battery voltage; a light emitting diode or array of light emitting diodes; and a power supply including a boost regulating circuit. The power supply being in communication with the battery and the light emitting diodes such that a constant voltage or constant current is supplied to the light emitting diodes as the battery discharges and the battery voltage falls below the output voltage. In a preferred embodiment the power supply further includes a buck regulator to maintain the proper output voltage when the battery voltage is greater than the output voltage.
Owner:SPORTSBEAMS LIGHTING INC

Anti-garp protein and uses thereof

The present invention relates to a protein binding to GARP in the presence of TGF-β and uses thereof.
Owner:ARGENX BVBA +1

Multi-staged fuel return system

A fuel system for an engine is provided herein. According to one embodiment, the fuel system includes a fuel supply coupled to a low pressure fuel pump, the low pressure fuel pump coupled to a high pressure fuel pump to provide fuel to a fuel rail. Further, the fuel system includes a plurality of injectors coupled to the fuel rail to provide fuel to a plurality of engine cylinders. Further still, the fuel system includes a first fuel return line coupling the fuel rail to the fuel supply and a thermal recirculation valve, the thermal recirculation valve further coupled to a low pressure pump intake line; a second fuel return line coupling the high pressure fuel pump to the first fuel return line; and a third fuel return line coupling the plurality of injectors to a high pressure pump intake line.
Owner:FORD GLOBAL TECH LLC

Aminopyrazole compounds

Described herein are aminopyrazole compounds of formula I: wherein R1, R2, L and Ar are as defined in the specification. Such compounds are capable of modulating the activity of a checkpoint kinase and methods for utilizing such modulation to treat cell proliferative disorders. Also described are pharmaceutical compositions containing such compounds. Also described are the therapeutic or prophylactic use of such compounds and compositions, and methods of treating cancer as well as other diseases associated with unwanted cellular proliferation, by administering effective amounts of such compounds in combination with anti-neoplastic agents.
Owner:AGOURON PHARMA INC

Production of multivalent virus like particles

The present invention is directed to the production and in vitro assembly of recombinant viral capsid proteins into virus like particles. In particular, the present invention provides rapid, scalable, and cost efficient methods for the production of multivalent virus like particles utilizing separate populations of capsid fusion peptides containing differing antigenic peptide inserts that are combined in vitro to produce homogenous populations of multivalent virus like particles. The virus like particles produced according to the present invention can be utilized to induce an immunological response in human or animal.
Owner:PFENEX

Battery discharge current sharing in a tightly regulated power system

In a high power system, plural batteries provide back-up power when primary power is unavailable. Each battery has an associated discharge controller which is controlled by a local bus control amplifier which regulates the power bus voltage set-point lower than the main bus voltage set-point. A single main bus control amplifier tightly regulates the power bus to a main bus voltage set-point and controls charging and discharging of all batteries to prevent charging of one battery at the expense (discharge) of another battery. There is one master battery discharge controller, with the remaining controllers being slave units. A local bus voltage set-point of each slave unit varies under the control of a slave unit current sharing amplifier which compares its own discharge current to the average discharge current, and an error signal modifies the reference voltage in the local bus control amplifier to allow equal discharge current from all batteries.
Owner:THE BOEING CO

Compositions and methods for the modification of physiological responses in plants

A gene expression system for controllable expression of ethylene response in a plant cell includes an activation cassette comprising a DNA-binding domain that recognizes a response element; an ecdysone receptor ligand binding domain; and an activation domain; and a target cassette comprising an inducible promoter, which comprises, in operative association, the response element and a minimal promoter responsive to the activation domain. The inducible promoter controls the expression of a nucleic acid sequence that encodes a selected protein that modifies sensitivity to ethylene in the plant. Interaction among the components of the activation cassette and target cassette, when in a plant cell, in the presence of an inducing composition, modulates expression of the selected protein and selectively modulates ethylene sensitivity in the plant cell. This modulation in the expression of the protein is controlled by the timing, the concentration and the duration of the application of the inducing composition. Transgenic plant cells, tissues, organs and entire plants are provided, which in the presence of the inducing composition control ethylene sensitivity. Ethylene sensitivity and / or ethylene production in such transgenic plants and tissues may be controlled for purposes of manipulating ripening, flower senescence and other ethylene sensitive functions of the plant.
Owner:AGROFRESH

Battery discharge current sharing in a tightly regulated power system

In a high power system, plural batteries provide back-up power when primary power is unavailable. Each battery has an associated discharge controller which is controlled by a local bus control amplifier which regulates the power bus voltage set-point lower than the main bus voltage set-point. A single main bus control amplifier tightly regulates the power bus to a main bus voltage set-point and controls charging and discharging of all batteries to prevent charging of one battery at the expense (discharge) of another battery. There is one master battery discharge controller, with the remaining controllers being slave units. A local bus voltage set-point of each slave unit varies under the control of a slave unit current sharing amplifier which compares its own discharge current to the average discharge current, and an error signal modifies the reference voltage in the local bus control amplifier to allow equal discharge current from all batteries.
Owner:THE BOEING CO

Treatment of disease using an improved regulated expression system

The present invention provides an improved, expression system for the regulated expression of an encoded protein or nucleic acid therapeutic molecule in the cells of a subject, for use in the treatment of disease. In particular, the present invention provides an improved, regulated gene expression system, and pharmaceutical compositions and uses thereof for treatment of disease.
Owner:BAYER SCHERING PHARMA AG

Molecular switch for regulating mammalian gene expression

Expression vectors are disclosed that are comprised of (a) one or more silencer elements and conditionally inducible elements to form silencer-inducible regions and (b) promoters in operative linkage upstream of at least one expressed region. The expression vector thereby regulates expression of at least one downstream region by conditional silencing in which an expressed DNA region of a gene is transcribed to produce RNA transcripts, which may or may not be translated to produce polypeptides. Genetically engineered mammalian cells and non-human mammals can be made using such expression vectors through transfection and transgenesis techniques. Moreover, processes of making and using the aforementioned products are disclosed (e.g., the expression vector may be used diagnostically, therapeutically, or prophylactically).
Owner:KEITH WEBSTER +1

Interferon-beta gene therapy using an improved, regulated expression system

InactiveUS20080076729A1Minimize side effectsMaximizing therapeutic efficacyGenetic material ingredientsPeptidesDiseaseInterferon alpha
The present invention provides an improved, expression system for the regulated expression of an encoded protein or nucleic acid therapeutic molecule in the cells of a subject, for use in the treatment of disease. In particular, the present invention provides an improved, regulated gene expression system, and pharmaceutical compositions and uses thereof for treatment of disease.
Owner:SCHERING AG

GM-CSF gene therapy for Crohn's disease using an improved regulated expression system

The present invention provides an improved, expression system for the regulated expression of an encoded protein or nucleic acid therapeutic molecule in the cells of a subject, for use in the treatment of disease. In particular, the present invention provides an improved, regulated gene expression system, and pharmaceutical compositions and uses thereof for treatment of disease.
Owner:SCHERING ELLACHFT

Control of targeted turnover of key ethylene hormone signaling pathway proteins to modulate ethylene sensitivity in plants

A gene expression system for controllable expression of ethylene response in a plant cell includes an activation cassette comprising a DNA-binding domain that recognizes a response element; an ecdysone receptor ligand binding domain; and an activation domain; and a target cassette comprising an inducible promoter, which comprises, in operative association, the response element and a minimal promoter responsive to the activation domain. The inducible promoter controls the expression of a nucleic acid sequence that encodes a selected regulatory protein that modifies sensitivity to ethylene of certain signal proteins in the plant. Interaction among the components of the activation cassette and target cassette, when in a plant cell, in the presence of an inducing composition, increases expression of the selected regulatory protein, and in turn decreases expression and accumulation of the signal protein in the plant, thereby and decreasing ethylene sensitivity in the plant cell. This increase in the expression of the regulatory protein, particularly in the presence of ethylene, is controlled by the timing, the concentration and the duration of the application of the inducing composition. Transgenic plant cells, tissues, organs and entire plants are provided, which in the presence of the inducing composition control ethylene sensitivity. Ethylene sensitivity and / or ethylene production in such transgenic plants and tissues may be controlled for purposes of manipulating ripening, flower senescence and other ethylene sensitive functions of the plant.
Owner:AGROFRESH

Control of targeted turnover of key ethylene hormone signaling pathway proteins to modulate ethylene sensitivity in plants

A gene expression system for controllable expression of ethylene response in a plant cell includes an activation cassette comprising a DNA-binding domain that recognizes a response element; an ecdysone receptor ligand binding domain; and an activation domain; and a target cassette comprising an inducible promoter, which comprises, in operative association, the response element and a minimal promoter responsive to the activation domain. The inducible promoter controls the expression of a nucleic acid sequence that encodes a selected regulatory protein that modifies sensitivity to ethylene of certain signal proteins in the plant. Interaction among the components of the activation cassette and target cassette, when in a plant cell, in the presence of an inducing composition, increases expression of the selected regulatory protein, and in turn decreases expression and accumulation of the signal protein in the plant, thereby and decreasing ethylene sensitivity in the plant cell. This increase in the expression of the regulatory protein, particularly in the presence of ethylene, is controlled by the timing, the concentration and the duration of the application of the inducing composition. Transgenic plant cells, tissues, organs and entire plants are provided, which in the presence of the inducing composition control ethylene sensitivity. Ethylene sensitivity and / or ethylene production in such transgenic plants and tissues may be controlled for purposes of manipulating ripening, flower senescence and other ethylene sensitive functions of the plant.
Owner:AGROFRESH

Interferon-beta gene therapy using an improved, regulated expression system

The present invention provides an improved, expression system for the regulated expression of an encoded protein or nucleic acid therapeutic molecule in the cells of a subject, for use in the treatment of disease. In particular, the present invention provides an improved, regulated gene expression system, and pharmaceutical compositions and uses thereof for treatment of disease.
Owner:SCHERING AG

Compositions and methods for self-regulated inducible gene expression

A self-regulating gene expression construct comprises a single promoter in operative association with a repressor sequence (e.g., bacterial repressor lacI or gaiR), operator sequence(s) responsive to the expressed repressor protein, and a transgene. A dual-regulating construct comprises a single promoter controlling expression of a bacterial repressor sequence and a transgene, and which, in the presence of a first inducer molecule, transcribes the transgene and repressor; and a ribozyme in association with an aptamer sequence, the aptamer sequence capable of interacting with a second inducer molecule to terminate mRNA degradation by the ribozyme. Also provided are recombinant vectors or viruses containing the self-regulating or dual self-regulating constructs and cells containing the vectors. Such compositions are useful in methods of treating a diseases using gene therapy.
Owner:THE TRUSTEES OF THE UNIV OF PENNSYLVANIA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products